Multiple-Point Evaluation Algorithms for Enhanced Precision of Pathogen-Specific Cerebrospinal Fluid/Serum Antibody...

Area of Science:

• Clinical Chemistry
• Immunology
• Neurology

Background:

• Accurate determination of pathogen-specific antibody indices (AIs) in cerebrospinal fluid (CSF) and serum is crucial for diagnosing neurological diseases.
• Current ELISA kit methodologies often rely on single optical density (OD) pairs for AI calculation, neglecting valuable measurement data and potentially introducing errors.

Purpose of the Study:

• To reanalyze existing ELISA OD data using advanced statistical methods to improve the precision of antibody index calculations.
• To evaluate the impact of multi-point evaluation strategies on the accuracy and reliability of AI determination for MRZH infections.

Main Methods:

• Reanalysis of OD data from Siemens Enzygnost ELISA proficiency survey samples (2012-2016) for measles/rubella/varicella zoster/herpes simplex virus (MRZH).
• Application of reference methods involving multiple-point evaluation, including the alpha method and the four-parameter logistic (4PL) equation, for Q value calculation.
• Comparison of AI precision derived from single-pair OD evaluation versus multiple-point evaluation.

Main Results:

• Multi-point evaluation significantly reduced the standard deviation of relative AI differences compared to single-pair evaluation.
• The hit rate within a 10% AI target environment improved from 49% to 69% on average across viruses.
• Parameter fitting, waiving standard curves, enhanced calculational precision for Siemens Enzygnost assays.

Conclusions:

• Employing multiple-point evaluation strategies for OD data significantly enhances the precision and accuracy of antibody index calculations in neurological disease diagnostics.
• This improved methodology offers potential benefits for patient safety, diagnostic assay cost-effectiveness, and laboratory efficiency, applicable to various test distributors.